TY  - GEN
AU  - Mateos,María-Victoria
AU  - Gutiérrez,Norma C
AU  - Martín-Ramos,María-Luisa
AU  - Paiva,Bruno
AU  - Montalbán,María-Angeles
AU  - Oriol,Albert
AU  - Martínez-López,Joaquín
AU  - Teruel,Ana-Isabel
AU  - Bengoechea,Enrique
AU  - Martín,Alejandro
AU  - Díaz-Mediavilla,Joaquín
AU  - de Arriba,Felipe
AU  - Palomera,Luis
AU  - Hernández,José-Mariano
AU  - Sureda,Anna
AU  - Bargay,Joan
AU  - Peñalver,Francisco-Javier
AU  - Ribera,Josep-Maria
AU  - Martín-Mateos,María-Luisa
AU  - Fernández,Manuela
AU  - García-Sanz,Ramón
AU  - Vidriales,María-Belén
AU  - Bladé,Joan
AU  - Lahuerta,Juan-José
AU  - San Miguel,Jesús F
TI  - Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance
SN  - 1528-0020
PY  - 2012///0103
KW  - Aged
KW  - Aged, 80 and over
KW  - Algorithms
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Boronic Acids
KW  - Bortezomib
KW  - Chromosome Aberrations
KW  - DNA, Neoplasm
KW  - genetics
KW  - Drug Administration Schedule
KW  - Humans
KW  - Induction Chemotherapy
KW  - methods
KW  - Maintenance Chemotherapy
KW  - Multiple Myeloma
KW  - diagnosis
KW  - Ploidies
KW  - Prognosis
KW  - Pyrazines
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2011-04-345801
ER  -